LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 44.42 | 17.25 | 1 | 3895 | 0.0003 | -0.3053 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 44.42 | 17.25 | 800 | 3895 | 0.2054 | 0.6334 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 44.42 | 17.25 | 21 | 3895 | 0.0054 | 0.0255 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 44.42 | 17.25 | 896 | 3895 | 0.2300 | 0.6573 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 46.39 | 17.25 | 1 | 4141 | 0.0002 | -0.3024 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 46.39 | 17.25 | 814 | 4141 | 0.1965 | 0.6281 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 46.39 | 17.25 | 16 | 4141 | 0.0039 | -0.0095 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 46.39 | 17.25 | 874 | 4141 | 0.2110 | 0.6428 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 48.36 | 17.25 | 1 | 4390 | 0.0002 | -0.2998 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 48.36 | 17.25 | 810 | 4390 | 0.1845 | 0.6188 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 48.36 | 17.25 | 7 | 4390 | 0.0016 | -0.1067 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 48.36 | 17.25 | 888 | 4390 | 0.2023 | 0.6375 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 50.33 | 17.25 | 1 | 4651 | 0.0002 | -0.2972 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 50.33 | 17.25 | 755 | 4651 | 0.1623 | 0.5968 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 50.33 | 17.25 | 3 | 4651 | 0.0006 | -0.1948 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 50.33 | 17.25 | 858 | 4651 | 0.1845 | 0.6223 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 52.30 | 17.25 | 1 | 4798 | 0.0002 | -0.2958 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 52.30 | 17.25 | 767 | 4798 | 0.1598 | 0.5957 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 52.30 | 17.25 | 1 | 4798 | 0.0002 | -0.2958 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 52.30 | 17.25 | 843 | 4798 | 0.1757 | 0.6144 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 54.27 | 17.25 | 1 | 4884 | 0.0002 | -0.2951 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 54.27 | 17.25 | 742 | 4884 | 0.1519 | 0.5869 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 54.27 | 17.25 | 1 | 4884 | 0.0002 | -0.2951 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 54.27 | 17.25 | 820 | 4884 | 0.1679 | 0.6065 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 56.24 | 17.25 | 1 | 4929 | 0.0002 | -0.2947 | MN20160310_N02 | J14 |